4o91
From Proteopedia
(Difference between revisions)
| Line 1: | Line 1: | ||
| - | ''' | + | ==Crystal Structure of type II inhibitor NG25 bound to TAK1-TAB1== |
| - | + | <StructureSection load='4o91' size='340' side='right' caption='[[4o91]], [[Resolution|resolution]] 2.39Å' scene=''> | |
| - | + | == Structural highlights == | |
| - | + | <table><tr><td colspan='2'>[[4o91]] is a 1 chain structure. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=4O91 OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=4O91 FirstGlance]. <br> | |
| - | + | </td></tr><tr><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=NG2:N-{4-[(4-ETHYLPIPERAZIN-1-YL)METHYL]-3-(TRIFLUOROMETHYL)PHENYL}-4-METHYL-3-(1H-PYRROLO[2,3-B]PYRIDIN-4-YLOXY)BENZAMIDE'>NG2</scene><br> | |
| - | + | <tr><td class="sblockLbl"><b>Activity:</b></td><td class="sblockDat"><span class='plainlinks'>[http://en.wikipedia.org/wiki/Mitogen-activated_protein_kinase_kinase_kinase Mitogen-activated protein kinase kinase kinase], with EC number [http://www.brenda-enzymes.info/php/result_flat.php4?ecno=2.7.11.25 2.7.11.25] </span></td></tr> | |
| - | + | <tr><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=4o91 FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=4o91 OCA], [http://www.rcsb.org/pdb/explore.do?structureId=4o91 RCSB], [http://www.ebi.ac.uk/pdbsum/4o91 PDBsum]</span></td></tr> | |
| + | <table> | ||
| + | __TOC__ | ||
| + | </StructureSection> | ||
| + | [[Category: Mitogen-activated protein kinase kinase kinase]] | ||
| + | [[Category: Gurbani, D.]] | ||
| + | [[Category: Hunter, J C.]] | ||
| + | [[Category: Tan, L.]] | ||
| + | [[Category: Westover, K D.]] | ||
| + | [[Category: Mitogen-activated protein kinase kinase kinase 7]] | ||
| + | [[Category: Serine/threonine kinase which acts as an essential component of the map kinase signal transduction pathway]] | ||
| + | [[Category: Tgf-beta-activated kinase 1 and map3k7-binding protein 1]] | ||
| + | [[Category: Tgf-beta-activated kinase 1 and map3k7-binding protein 1 chimera]] | ||
| + | [[Category: Transferase-transferase inhibitor complex]] | ||
Revision as of 07:48, 30 July 2014
Crystal Structure of type II inhibitor NG25 bound to TAK1-TAB1
| |||||||||||
Categories: Mitogen-activated protein kinase kinase kinase | Gurbani, D. | Hunter, J C. | Tan, L. | Westover, K D. | Mitogen-activated protein kinase kinase kinase 7 | Serine/threonine kinase which acts as an essential component of the map kinase signal transduction pathway | Tgf-beta-activated kinase 1 and map3k7-binding protein 1 | Tgf-beta-activated kinase 1 and map3k7-binding protein 1 chimera | Transferase-transferase inhibitor complex
